Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases

Tumor Biology

Volumn 37, Issue 10, 2016, Pages 14025-14034

  Baruah, Meghna M ^a   Khandwekar, Anand P ^a   Sharma, Neeti ^a  

^a SYMBIOSIS INTERNATIONAL DEEMED UNIVERSITY   (India)

Author keywords

E cadherin; EMT; N cadherin; quercetin; TGF ; Wnt

Indexed keywords

NERVE CELL ADHESION MOLECULE; QUERCETIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TWIST RELATED PROTEIN 1; UVOMORULIN; VIMENTIN; ANTIOXIDANT; CADHERIN; CDH1 PROTEIN, HUMAN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; WNT PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IC50; MALE; METASTASIS INHIBITION; MIGRATION INHIBITION; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WNT SIGNALING PATHWAY; APOPTOSIS; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PATHOLOGY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CADHERINS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PROSTATIC NEOPLASMS; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; WNT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84982993509     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-5277-6     Document Type: Article

References (45)

1. Siegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):29.
2. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818–29.
3. Grant CM, Kyprianou N. Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression. Transl Androl Urol. 2013;2(4):202–11.
4. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.
5. Moustakas A, Heldin P. Biochimica et Biophysica Acta TGF β and matrix-regulated epithelial to mesenchymal transition ☆. BBA - Gen Subj. 2014;1840(8):2621–2634.
6. Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest. 2002;109(12):1551–9.
7. Zavadil J, Böttinger EP. TGF-β and epithelial-to-mesenchymal transitions. Oncogene. 2005;24(37):5764–74.
8. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. Nature Publishing Group2012;13(1):11–26.
9. Valkenburg KC, Graveel CR, Zylstra-Diegel CR, Zhong Z, Williams BO. Wnt/β-catenin signaling in normal and cancer stem cells. Cancers (Basel). 2011;3(2):2050–79.
10. Baruah MM, Sharma N. Effect of flavonoid on reversal of TGF-β induced epithelial to mesenchymal transition in prostate cancer (PC-3) cell line. Ind J Clin Biochem. 2015;30(1):S83.
11. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets. 2010;9(4):263–85.
12. Papiez MA, Cierniak A, Krzysciak W, Bzowska M, Taha HM, Jozkowicz A, et al. The changes of antioxidant defense system caused by quercetin administration do not lead to DNA damage and apoptosis in the spleen and bone marrow cells of rats. Food Chem Toxicol. 2008;46(9):3053–8.
13. Baruah MM, Sharma N, Khandwekar AP, Lavale G-, Author C. Flavonoids and Prostate Cancer. AIJRFANS. 2016;15(1):01–07.
14. Kim GT, Lee SH, Kim II J, Kim YM. Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner. Int J Mol Med. 2014;33(4):863–9.
15. Chan S-T, Yang N-C, Huang C-S, Liao J-W, Yeh S-L. Quercetin enhances the antitumor activity of trichostatin a through upregulation of p53 protein expression in vitro and in vivo. PLoS One 2013;8(1):e54255.
16. Shan B-E, Wang M-X, Li R. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Investig. 2009;27(6):604–12.
17. Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol. 2004;281:301–11.
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101–8.
19. BD Biosciences. Caspase-3 Activation: an indicator of apoptosis in image-based assays. BD Biosciences. 2012. https://www.bdbiosciences.com/documents/Bioimaging_AppNote_Apoptosis.pdf. Accessed 10 Nov 2015.
20. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184(1):39–51.
21. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci. 2005;118(19):4325–6.
22. Nistico P, Bissell MJ, Radisky DC. Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol. 2012;4(2):a011908.
23. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–21.
24. Zhong H, Marzo AM De, Laughner E, Lim M, Hilton D A, Zagzag D, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases 1. New York. 2000;(22):5830–5.
25. Son H, Moon A. Epithelial-mesenchymal transition and cell invasion. Toxicol Res. 2010;26(4):245–52.
26. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 2008;27:6958–69.
27. López-Nouoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009;1(6–7):303–14.
28. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol. 2006;174(2):175–83.
29. Nawshad A, LaGamba D, Polad A, Hay ED. Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 2005;179(1–2):11–23.
30. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005;24(50):7443–54.
31. Malage RD. Studies on regulation of TGF-β and markers of epithelial to mesenchymal transition in breast cancer cells. Dissertation, Jawaharlal Nehru University. 2008;110067.
32. Chen D, Wilkinson CRM, Watt S, Penkett CJ, Toone WM, Jones N, et al. Multiple pathways differentially regulate global oxidative stress responses in fission yeast. Mol Biol Cell. 2008;19(1):308–17.
33. Moustakas A, Heldin C-HH. The regulation of TGFbeta signal transduction. Development. 2009;136(22):3699–714.
34. Lin YS, Tsai PH, Kandaswami CC, Cheng CH, Ke FC, Lee PP, et al. Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells. Cancer Sci. 2011;102(10):1829–39.
35. Deng XH, Song HY, Zhou YF, Yuan GY, Zheng FJ. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med. 2013;6(5):1155–8.
36. Salem-Alrawaiq N, Abdullah A. A review of flavonoid quercetin: metabolism, bioactivity and antioxidant properties. Int J PharmTech Res. 2014;6(3):933–41.
37. Uygur B, Wu W-S. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer BioMed Central Ltd; 2011;10(1):139.
38. Zhang K, Chen D, Jiao X, Zhang S, Liu X, Cao J, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Investig. Nature Publishing Group2011;91(3):426–38.
39. Kurrey NK, Amit K, Bapat SA. Snail and slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol. 2005;97(1):155–65.
40. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Ben Gurion University of the Negev. Cell. 2004;117:927–39.
41. Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, et al. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem. Elsevier Inc.2014;25(11):1132–9.
42. Kim H, Seo EM, Sharma AR, Ganbold B, Park J, Sharma G, et al. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells. Int J Oncol. 2013;43(4):1319–25.
43. Novo MCT, Osugui L, dos Reis VO, Longo-Maugeri IM, Mariano M, Popi AF. Blockage of Wnt/β-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro. Immunobiology Elsevier GmbH.; 2015;220(1):60–67.
44. Maso V, Calgarotto AKA, Franchi GCA, Nowill AED, Filho PLA, Vassallo J, et al. Multitarget effects of quercetin in leukemia. Cancer Prev Res (Phila). 2014;7(12):1240–50.
45. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res. American Society for Investigative Pathology2008;68(23):9574–7.